{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:01:49Z","timestamp":1782864109431,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore prognostic factors of postoperative hepatocellular carcinoma (HCC) and compare the prognostic performance of the tumor\u2013node\u2013metastasis (TNM) system with an integrated clinicopathological model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cohort study evaluating 249 patients with HCC who underwent radical liver resection between January 2015 and December 2024. Overall survival (OS) was the primary endpoint. Independent prognostic factors were determined using the Cox proportional hazards model. Model performance was assessed using the correlation index (C-index) with bootstrap internal validation. Time-dependent receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots were used to assess discrimination, clinical utility, and agreement between predicted and observed outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In multivariable analysis, TNM stage, microvascular invasion (MVI), resection margin status, and albumin\u2013bilirubin (ALBI) grade were independent predictors of OS. For recurrence-free survival (RFS), independent predictors included hepatitis status, ALBI grade, TNM stage, and MVI. The integrated model demonstrated improved discrimination compared with TNM alone, with a higher optimism-corrected C-index (0.676 vs. 0.647). Time-dependent ROC analysis showed significantly higher AUC values for the integrated model at 1 year (0.725 vs. 0.669,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046), 3 years (0.703 vs. 0.657,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), and 5 years (0.684 vs. 0.649,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031). DCA indicated greater net benefit across clinically relevant thresholds, and calibration plots showed good agreement between predicted and observed survival probabilities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An integrated clinicopathological model incorporating TNM stage, MVI, ALBI grade, and resection margin status improves prognostic performance compared with TNM alone in patients undergoing curative resection for HCC. This model may support more accurate postoperative risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-04895-2","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:44:16Z","timestamp":1778118256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated clinicopathological model versus TNM for predicting survival in resected hepatocellular carcinoma: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2580-0955","authenticated-orcid":false,"given":"Gia Anh","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-2415","authenticated-orcid":false,"given":"Trung Nghia","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-2322","authenticated-orcid":false,"given":"Tien Cong","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-9475","authenticated-orcid":false,"given":"Manh Thau","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Son","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1127-2233","authenticated-orcid":false,"given":"Thi Huyen Trang","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6693-9416","authenticated-orcid":false,"given":"Thanh Tung","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2821-7488","authenticated-orcid":false,"given":"Thi Thu Hang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6405-9048","authenticated-orcid":false,"given":"Thanh Lam","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0397-011X","authenticated-orcid":false,"given":"Thu Hang","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5601-0701","authenticated-orcid":false,"given":"Thi Ngoc","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"4895_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"key":"4895_CR2","doi-asserted-by":"publisher","unstructured":"Li J, Liang Y-B, Chen X-M, Ou Z-Y, Wang Q-B, Luo W-L et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front Immunol. 17:1714314. https:\/\/doi.org\/10.3389\/fimmu.2026.1714314.","DOI":"10.3389\/fimmu.2026.1714314"},{"key":"4895_CR3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/hep4.1923","volume":"6","author":"RF Reveron-Thornton","year":"2022","unstructured":"Reveron-Thornton RF, Teng MLP, Lee EY, Tran A, Vajanaphanich S, Tan EX, et al. Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies. Hepatol Commun. 2022;6:1813\u201326. https:\/\/doi.org\/10.1002\/hep4.1923.","journal-title":"Hepatol Commun"},{"key":"4895_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3349\/ymj.2024.0087","volume":"66","author":"NR Kim","year":"2025","unstructured":"Kim NR, Choi GH, Han DH, Kim KS, Choi JS. Significant Improvement in Long-Term Survival after Liver Resection for Hepatocellular Carcinoma: Evolving Outcomes over 20 Years. Yonsei Med J. 2025;66:637\u201346. https:\/\/doi.org\/10.3349\/ymj.2024.0087.","journal-title":"Yonsei Med J"},{"key":"4895_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ags3.12212","volume":"3","author":"F Sonohara","year":"2018","unstructured":"Sonohara F, Yamada S, Tanaka N, Suenaga M, Takami H, Hayashi M, et al. Perioperative and prognostic implication of albumin-bilirubin\u2010TNM score in Child\u2010Pugh class A hepatocellular carcinoma. Ann Gastroenterol Surg. 2018;3:65\u201374. https:\/\/doi.org\/10.1002\/ags3.12212.","journal-title":"Ann Gastroenterol Surg"},{"key":"4895_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.21037\/jgo-23-427","volume":"14","author":"S Huang","year":"2023","unstructured":"Huang S, Zhu Z, Ruan Y, Zhang F, Xu Y, Jin L, et al. Prognostic factors and survival prediction in hepatocellular carcinoma: development and validation of a novel nomogram based on the SEER database. J Gastrointest Oncol. 2023;14:1817\u201329. https:\/\/doi.org\/10.21037\/jgo-23-427.","journal-title":"J Gastrointest Oncol"},{"key":"4895_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12967-024-05296-3","volume":"22","author":"S-P Xiong","year":"2024","unstructured":"Xiong S-P, Wang C-H, Zhang M, Yang X, Yun J-P, Liu L-L. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients. J Transl Med. 2024;22:472. https:\/\/doi.org\/10.1186\/s12967-024-05296-3.","journal-title":"J Transl Med"},{"key":"4895_CR8","doi-asserted-by":"publisher","unstructured":"Vitale A, Farinati F, Finotti M, Renzo CD, Brancaccio G, Piscaglia F, et al. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications. Cancers. 2021;13. https:\/\/doi.org\/10.3390\/cancers13071673.","DOI":"10.3390\/cancers13071673"},{"key":"4895_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12957-017-1292-3","volume":"15","author":"YK Park","year":"2017","unstructured":"Park YK, Song SK, Kim B-W, Park S-K, Chung C-W, Wang H-J. Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma. World J Surg Oncol. 2017;15:225. https:\/\/doi.org\/10.1186\/s12957-017-1292-3.","journal-title":"World J Surg Oncol"},{"key":"4895_CR10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1245\/s10434-008-9846-9","volume":"15","author":"S Sumie","year":"2008","unstructured":"Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375\u201382. https:\/\/doi.org\/10.1245\/s10434-008-9846-9.","journal-title":"Ann Surg Oncol"},{"key":"4895_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.hpb.2018.11.005","volume":"21","author":"J Han","year":"2019","unstructured":"Han J, Li Z-L, Xing H, Wu H, Zhu P, Lau WY, et al. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB. 2019;21:962\u201371. https:\/\/doi.org\/10.1016\/j.hpb.2018.11.005.","journal-title":"HPB"},{"key":"4895_CR12","doi-asserted-by":"publisher","first-page":"9567041","DOI":"10.1155\/2022\/9567041","volume":"2022","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Guan R, Jianxi W, Zhao Z, Peng T, Liu C, et al. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. J Oncol. 2022;2022:9567041. https:\/\/doi.org\/10.1155\/2022\/9567041.","journal-title":"J Oncol"},{"key":"4895_CR13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/MEG.0000000000003028","volume":"37","author":"S Shi","year":"2025","unstructured":"Shi S, Cui X, Liu C, Li H, Zhai R. Significance of surgical resection and resection margins for hepatocellular carcinoma with microvascular invasion: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2025;37:1283\u201391. https:\/\/doi.org\/10.1097\/MEG.0000000000003028.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4895_CR14","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1093\/oncolo\/oyad124","volume":"28","author":"J Liu","year":"2023","unstructured":"Liu J, Zhuang G, Bai S, Hu Z, Xia Y, Lu C, et al. The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion. Oncologist. 2023;28:e1043\u201351. https:\/\/doi.org\/10.1093\/oncolo\/oyad124.","journal-title":"Oncologist"},{"key":"4895_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/MEG.0000000000001618","volume":"32","author":"L Geng","year":"2020","unstructured":"Geng L, Zong R, Shi Y, Xu K. Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32:769\u201378. https:\/\/doi.org\/10.1097\/MEG.0000000000001618.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4895_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.14701\/ahbps.2018.22.4.335","volume":"22","author":"YH Lee","year":"2018","unstructured":"Lee YH, Koh YS, Hur YH, Cho CK, Kim HJ, Park EK. Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinoma. Ann Hepato-Biliary-Pancreat Surg. 2018;22:335\u201343. https:\/\/doi.org\/10.14701\/ahbps.2018.22.4.335.","journal-title":"Ann Hepato-Biliary-Pancreat Surg"},{"key":"4895_CR17","doi-asserted-by":"publisher","unstructured":"Lee JJB, Park JS, Hong HP, Kim MS, Koo D-H, Lee H, et al. Evaluation of Pretreatment Albumin\u2013Bilirubin Grade as a Better Prognostic Factor Compared to Child\u2013Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy. J Pers Med. 2023;13. https:\/\/doi.org\/10.3390\/jpm13020354.","DOI":"10.3390\/jpm13020354"},{"key":"4895_CR18","doi-asserted-by":"publisher","unstructured":"Marasco G, Alemanni LV, Colecchia A, Festi D, Bazzoli F, Mazzella G, et al. Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis. J Clin Med. 2021;10. https:\/\/doi.org\/10.3390\/jcm10092011.","DOI":"10.3390\/jcm10092011"},{"key":"4895_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/hepr.12796","volume":"47","author":"M-X Li","year":"2017","unstructured":"Li M-X, Zhao H, Bi X-Y, Li Z-Y, Huang Z, Han Y, et al. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort. Hepatol Res Off J Jpn Soc Hepatol. 2017;47:731\u201341. https:\/\/doi.org\/10.1111\/hepr.12796.","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"key":"4895_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76:681\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018.","journal-title":"J Hepatol"},{"key":"4895_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.5858\/arpa.2020-0032-RA","volume":"145","author":"X Liao","year":"2021","unstructured":"Liao X, Zhang D. The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update. Arch Pathol Lab Med. 2021;145:543\u201353. https:\/\/doi.org\/10.5858\/arpa.2020-0032-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"4895_CR22","unstructured":"Management of Hepatocellular Carcinoma | AASLD. https:\/\/www.aasld.org\/practice-guidelines\/management-hepatocellular-carcinoma. Accessed 21 Mar 2026."},{"key":"4895_CR23","unstructured":"EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma - Journal of Hepatology. https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(18)30215-0\/fulltext. Accessed 21 Mar 2026."},{"key":"4895_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3748\/wjg.v16.i4.501","volume":"16","author":"S-D Wu","year":"2010","unstructured":"Wu S-D, Wang J-Y, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study. World J Gastroenterol WJG. 2010;16:501\u20137. https:\/\/doi.org\/10.3748\/wjg.v16.i4.501.","journal-title":"World J Gastroenterol WJG"},{"key":"4895_CR25","unstructured":"Establishment and Validation of a Prognostic Nomogram Model for Radica | JHC. https:\/\/www.dovepress.com\/an-inflammation-associated-prognostic-model-for-hepatocellular-carcino-peer-reviewed-fulltext-article-JHC. Accessed 25 Jan 2026."},{"key":"4895_CR26","doi-asserted-by":"publisher","first-page":"28103","DOI":"10.1038\/s41598-024-79760-x","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang Z, Wu Q, Zeng J, Liu J, Zeng J. Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin. Sci Rep. 2024;14:28103. https:\/\/doi.org\/10.1038\/s41598-024-79760-x.","journal-title":"Sci Rep"},{"key":"4895_CR27","doi-asserted-by":"publisher","first-page":"109353","DOI":"10.1016\/j.ejso.2024.109353","volume":"51","author":"S Yang","year":"2025","unstructured":"Yang S, Ni H, Zhang A, Zhang J, Zang H, Ming Z. Significance of anatomical resection and wide surgical margin for HCC patients with MVI undergoing laparoscopic hepatectomy: A multicenter study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2025;51:109353. https:\/\/doi.org\/10.1016\/j.ejso.2024.109353.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"4895_CR28","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.26355\/eurrev_202303_31576","volume":"27","author":"W-D Lin","year":"2023","unstructured":"Lin W-D, Ye L-N, Song Z-S, Wang K-P, Feng Y-F, Pan C-Y. Wide surgical margins improve prognosis for HCC with microvascular invasion. Eur Rev Med Pharmacol Sci. 2023;27:2052\u20139. https:\/\/doi.org\/10.26355\/eurrev_202303_31576.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4895_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.21037\/atm.2020.02.116","volume":"8","author":"D Feng","year":"2020","unstructured":"Feng D, Wang M, Hu J, Li S, Zhao S, Li H, et al. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases. Ann Transl Med. 2020;8:553\u2013553. https:\/\/doi.org\/10.21037\/atm.2020.02.116.","journal-title":"Ann Transl Med"},{"key":"4895_CR30","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"Q-B Wang","year":"2025","unstructured":"Wang Q-B, Luo W-L, Li Y-K, Li J, Yang Z-S, Zhao K, et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2055\u201367. https:\/\/doi.org\/10.2147\/JHC.S544589.","journal-title":"J Hepatocell Carcinoma"},{"key":"4895_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cca.2018.06.020","volume":"485","author":"B-B Cai","year":"2018","unstructured":"Cai B-B, Shi K-Q, Li P, Chen B-C, Shi L, Johnson PJ, et al. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection. Clin Chim Acta Int J Clin Chem. 2018;485:187\u201394. https:\/\/doi.org\/10.1016\/j.cca.2018.06.020.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"4895_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JHC.S567300","volume":"13","author":"Y Zhai","year":"2026","unstructured":"Zhai Y, Gan B, Guan R, Lin Y, Lu Y. An Inflammation-Associated Prognostic Model for Hepatocellular Carcinoma Following Radical Resection. J Hepatocell Carcinoma. 2026;13:1\u201311. https:\/\/doi.org\/10.2147\/JHC.S567300.","journal-title":"J Hepatocell Carcinoma"},{"key":"4895_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00423-023-02993-3","volume":"408","author":"Z-C Qiu","year":"2023","unstructured":"Qiu Z-C, Li C, Zhang Y, Xie F, Yu Y, Leng S-S, et al. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection. Langenbecks Arch Surg. 2023;408:250. https:\/\/doi.org\/10.1007\/s00423-023-02993-3.","journal-title":"Langenbecks Arch Surg"},{"key":"4895_CR34","doi-asserted-by":"publisher","unstructured":"Liu F, Xiang Y, Xu H, Xu X. Preoperative serum inflammatory markers in the prognostic assessment of hepatocellular carcinoma resection in stages I\/II. Front Mol Biosci. 2025;12. https:\/\/doi.org\/10.3389\/fmolb.2025.1640390.","DOI":"10.3389\/fmolb.2025.1640390"},{"key":"4895_CR35","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"W-L Luo","year":"2025","unstructured":"Luo W-L, Wang Q-B, Li Y-K, Liang Y-B, Li J, Chen X-M, et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2681\u201392. https:\/\/doi.org\/10.2147\/JHC.S556306.","journal-title":"J Hepatocell Carcinoma"},{"key":"4895_CR36","doi-asserted-by":"publisher","unstructured":"Zhang J, Guo G, Li T, Guo C, Han Y, Zhou X. Development and validation of a prognostic nomogram for early hepatocellular carcinoma treated with microwave ablation. Front Oncol. 2025;15. https:\/\/doi.org\/10.3389\/fonc.2025.1486149.","DOI":"10.3389\/fonc.2025.1486149"},{"key":"4895_CR37","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1245\/s10434-016-5713-2","volume":"24","author":"J Zheng","year":"2017","unstructured":"Zheng J, Kuk D, G\u00f6nen M, Balachandran VP, Kingham TP, Allen PJ, et al. Actual Ten-Year Survivors after Resection of Hepatocellular Carcinoma. Ann Surg Oncol. 2017;24:1358\u201366. https:\/\/doi.org\/10.1245\/s10434-016-5713-2.","journal-title":"Ann Surg Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04895-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:29:52Z","timestamp":1782862192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04895-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9424158\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Viet Duc University Hospital, Hanoi, Vietnam (Approval No. IRB-VN01.021_2026.03). Due to the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by the ethics committee. All procedures were conducted in accordance with the Declaration of Helsinki.The requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"391"}}